Latest news

Thumbnail image for AZ' Imfinzi to be funded for NHS use via CDF

AZ' Imfinzi to be funded for NHS use via CDF

AstraZeneca’s PD-L1 inhibitor Imfinzi will be made available on the NHS in England immediately for patients with locally advanced unresectable non-small-cell lung cancer.

28th March 2019

Previous  --   2 3 4 5 6 7 8 9 10 11   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download